Related references
Note: Only part of the references are listed.Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Design and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2
Bishnu P. Joshi et al.
BIOCONJUGATE CHEMISTRY (2016)
Global Cancer Incidence and Mortality Rates and Trends-An Update
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Integrated monolithic 3D MEMS scanner for switchable real time vertical/horizontal cross-sectional imaging
Haijun Li et al.
OPTICS EXPRESS (2016)
In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft
Quan Zhou et al.
PHOTOACOUSTICS (2016)
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Sharon H. Giordano et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer
Melissa L. Korb et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Affinity Maturation of an ERBB2-Targeted SPECT Imaging Peptide by In Vivo Phage Display
Benjamin M. Larimer et al.
MOLECULAR IMAGING AND BIOLOGY (2014)
Optimal Sequencing of Anti-HER2 Therapy Throughout the Continuum of HER2-Positive Breast Cancer: Evidence and Clinical Considerations
Nadia Harbeck et al.
DRUGS (2013)
Targeted Imaging of Esophageal Neoplasia with a Fluorescently Labeled Peptide: First-in-Human Results
Matthew B. Sturm et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Pathology of Invasive Breast Disease
Adriana D. Corben
SURGICAL CLINICS OF NORTH AMERICA (2013)
When to order a biopsy to characterise a metastatic relapse in breast cancer
T. Foukakis et al.
ANNALS OF ONCOLOGY (2012)
Translation of Near-Infrared Fluorescence Imaging Technologies: Emerging Clinical Applications
E. M. Sevick-Muraca
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Understanding Food and Drug Administration Regulatory Requirements for an Investigational Device Exemption for Sponsor-Investigators
M. E. Blair Holbein et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2012)
Multimodal Imaging of Growth and Rapamycin-Induced Regression of Colonic Adenomas in Apc Mutation-Dependent Mouse
Sharon J. Miller et al.
TRANSLATIONAL ONCOLOGY (2012)
Peptide heterodimers for molecular imaging
Yongjun Yan et al.
AMINO ACIDS (2011)
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
Vikash P. Chauhan et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 2 (2011)
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
E. C. Dijkers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats
Milton V. Marshall et al.
MOLECULAR IMAGING AND BIOLOGY (2010)
Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI
Ting-Jung Chen et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer - Results of the sentinella/GIVOM trial
Giorgio Zavagno et al.
ANNALS OF SURGERY (2008)
Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer
Rebecca Crane-Okada et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy
Pei-Lin Hsiung et al.
NATURE MEDICINE (2008)
Drug insight: intracellular inhibitors of HER2 - clinical development of lapatinib in breast cancer
David A. Cameron et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
A systematic approach to the development agents for optical imaging of mouse of fluorescent contrast cancer models
Joy L. Kovar et al.
ANALYTICAL BIOCHEMISTRY (2007)
Role for intraoperative margin assessment in patients undergoing breast-conserving surgery
Neslihan Cabioglu et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Synthetic affibody molecules: A novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors
Anna Orlova et al.
CANCER RESEARCH (2007)
HEIZ2-Positive breast cancer - Current and future treatment strategies
Ryan H. Engel et al.
DRUGS (2007)
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
Patrick J. Perik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using In-111-trastuzumab (Herceptin) Fab fragments
Y Tang et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Arming antibodies: prospects and challenges for immunoconjugates
AM Wu et al.
NATURE BIOTECHNOLOGY (2005)
Medical progress - Ductal carcinoma in situ of the breast
HJ Burstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Large-scale manufacture of peptide therapeutics by chemical synthesis
BL Bray
NATURE REVIEWS DRUG DISCOVERY (2003)
Rationally engineered proteins or antibodies with absent or reduced immunogenicity
S Tangri et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Routine morphometrical analysis can improve reproducibility of dysplasia grade in Barrett's oesophagus surveilrance biopsies
JPA Baak et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Converting a peptide into a drug: Strategies to improve stability and bioavailability
C Adessi et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Share Paper
